Senator Orrin Hatch (R-Utah), the longest-tenured Republican senator, has sent a letter to the DEA asking for a delay in the scheduling of the pain-relieving plant, kratom. The main benefit from kratom users is pain relief, but the ancient plant has a unique quality compared to other pain medication; kratom is not an opioid.
Currently, doctors prescribe opioid pain medications that relieve patients from their excruciating symptoms, but at the cost of potentially becoming addicted to the medicine prescribed to them. Many kratom users switched to the plant in a dual effort to relieve pain, and reduce their dependency on addictive opioid drugs.
Unfortunately, kratom has recently been associated with other synthetic drugs, and the DEA is attempting to label kratom as a Schedule I drug under the Controlled Substance Act.
Being listed as a Schedule I drug puts kratom in the same category as heroin and LSD, while also stating it has “no medically accepted uses” in the United States. Kratom users will tell you that not only does it have medically accepted uses, but it also saved them from their deadly addiction to opioids.
Join this bi-partisan effort from congressmen in the House and Senate, and sign this petition telling the DEA to not schedule kratom until more scientific testing can be completed!